Dr. Kempton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
550 Peachtree St NE
Atlanta, GA 30308Phone+1 404-778-1900- Is this information wrong?
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2001 - 2004
- Oregon Health & Science UniversityResidency, Internal Medicine, 1997 - 2000
- Mayo Clinic College of MedicineClass of 1997
Certifications & Licensure
- OR State Medical License 1998 - Present
- GA State Medical License 2005 - 2025
- NC State Medical License 2001 - 2005
Clinical Trials
- Inhibitor Development in Patients With Hemophilia A Undergoing Surgery Start of enrollment: 2011 Nov 01
- Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B Start of enrollment: 2013 Feb 11
- Enoxaparin Dosing in Obesity Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- Defining the impact of immune tolerance induction on clinically relevant outcomes in a US cohort of severe hemophilia A.Christine L Kempton, Stacey A Fedewa> ;Blood Advances. 2024 Mar 12
- Race and ethnicity and the success of immune tolerance induction among people with severe haemophilia A in the United States.Stacey A Fedewa, Christine L Kempton> ;Haemophilia. 2024 Mar 10
- 2 citationsRace, ethnicity, and immune tolerance induction in hemophilia A in the United States.Christine L Kempton, Amanda B Payne, Stacey A Fedewa> ;Research and Practice in Thrombosis and Haemostasis. 2023 Nov 1
- Join now to see all
Journal Articles
- Emicizumab Prophylaxis in Patients Who Have Hemophilia A Without InhibitorsChristine Kempton, Gallia G Levy, Michael U Callaghan, The New England Journal of Medicine
Abstracts/Posters
- All-Cause and Inhibitor-Related Mortality in Non-Severe Hemophilia _ Patients in the United StatesChristine L. Kempton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3Christine L. Kempton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Validation of Instrument to Assess Hemophilia-Related Distress61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Hematologic Emergencies2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
- Hemophilia: A Disease in Transition60th American Society of Hematology Annual Meeting - 12/2/2018
Press Mentions
- Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data SuggestsJuly 22nd, 2022
- Gift from Hemophilia of Georgia Establishes Newly Renovated Bleeding and Clotting Disorders Center at EmorySeptember 13th, 2018
- ASH 2016 – Saturday, December 3December 3rd, 2015
- Join now to see all
Hospital Affiliations
- Emory University HospitalAtlanta, Georgia
- Emory University Hospital MidtownAtlanta, Georgia
- Grady Health SystemAtlanta, Georgia
- Southern Regional Medical CenterRiverdale, Georgia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: